- Accepted Abstracts will be published in Endocrine Practice, the official journal of AACE.
- Accepted Abstracts will have a poster presentation at the meeting.
- Top Abstracts will be selected for oral presentation at the meeting.
- In some cases, the committee may consider Late Breaking Abstracts for oral presentation.
Abstract Submission & Topics:
Clinical aspects of insulin resistance in childhood, adolescence and/or adulthood pertaining to:
Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea
Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain
Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease. Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.
The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level.
To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.
- Scientific materials presented at the 15th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2017) must not have been published or presented prior to November 30, 2017, other than in abstract form.
- All abstracts must be submitted electronically and no more than 500 words.
- All materials must arrive on or before the abstract deadline noted above.
- Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
- Authorship on multiple abstracts is permitted.
- All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
- Abstracts may be submitted for poster presentation. If selected for poster presentation, the author is required to register for the Congress and to be present during the poster sessions. Awards will be given for the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention. The authors of the winning abstracts will orally present their research findings during the Plenary Sessions in a ten minute presentation, to be followed by a five minute period of discussion.
- If selected for oral presentation, an author is required to register for the Congress and to be prepared for the oral presentation with a PowerPoint presentation. Abstracts must be accompanied by a statement from the authors agreeing that, if chosen, they will prepare a poster presentation, and that, if awarded a high ranking, they will prepare an oral presentation.
- Abstracts will be published in: Endocrine Practice.Editor-in-Chief – Derek Leroith, MD, PhD “Endocrine Practice is a peer-reviewed journal published six times a year, and is the official journal of the American Association of Clinical Endocrinologists (AACE). The first issue of Endocrine Practice was published in 1995. The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.”